HVP
GH icon

Hudson Value Partners’s Guardant Health GH Stock Holding History

Hudson Value Partners’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-9,340
Closed -$277K – 101
2023
Q3 		$277K Sell
9,340
-335
-3% -$11.8K 0.15% 90
2023
Q2 		$346K Sell
9,675
-2,575
-21% -$74K 0.18% 87
2023
Q1 		$287K Sell
12,250
-585
-5% -$16.7K 0.16% 93
2022
Q4 		$349K Sell
12,835
-3,800
-23% -$174K 0.21% 87
2022
Q3 		$895K Sell
16,635
-800
-5% -$41.1K 0.6% 47
2022
Q2 		$703K Buy
17,435
+7,550
+76% +$374K 0.45% 59
2022
Q1 		$655K Buy
9,885
+595
+6% +$40.7K 0.34% 69
2021
Q4 		$929K Sell
9,290
-930
-9% -$96.2K 0.45% 62
2021
Q3 		$1.28M Buy
10,220
+850
+9% +$101K 0.7% 46
2021
Q2 		$1.16M Buy
9,370
+242
+3% +$32.6K 0.64% 51
2021
Q1 		$1.39M Buy
9,128
+1,646
+22% +$249K 0.84% 38
2020
Q4 		$944K Buy
+7,482
New +$861K 0.63% 53

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hudson Value Partners's GH Position: Q4 2023 in Review

Hudson Value Partners sold out of Guardant Health (GH) in Q4 2023, closing a stake of 9,340 shares — an estimated $277K sold.

Hudson Value Partners first reported a position in GH in Q4 2020 and held it in 12 quarters. The position peaked at $1.39M in Q1 2021. 295 funds tracked by Wall St. Rank hold GH as of Q4 2023.

  • Hudson Value Partners reported no remaining Guardant Health position as of Q4 2023 after selling out during the quarter.
  • Hudson Value Partners sold 9,340 Guardant Health shares in Q4 2023, an estimated $277K.
  • Hudson Value Partners first reported a position in Guardant Health in Q4 2020 and held it in 12 quarters.
  • Hudson Value Partners's Guardant Health position peaked at $1.39M in Q1 2021.
  • 295 funds tracked by Wall St. Rank held Guardant Health as of Q4 2023.

Based on Hudson Value Partners's 13F filing for Q4 2023, filed 12 Feb 2024.